Sign in Subscribe
AIDS (Disease)

ViiV Healthcare Endorses Consensus Statement on Ending AIDS and HIV as a Public Health Threat in Europe by 2030

Strategic Insights

— 1 min read

A consensus statement on ending AIDS and HIV as a public health threat by 2030 was recently endorsed by ViiV Healthcare, calling for the European Union (EU) to make HIV, tuberculosis (TB), viral hepatitis, and sexually transmitted infections (STIs) a political, policy, and budgetary priority in the new EU Commission mandate from 2024 to 2029. This statement was developed in collaboration with the World Health Organization (WHO) Europe and the Joint United Nations Programme on HIV/AIDS (UNAIDS). The statement outlines essential steps for the European Commission and its Member States to take to meet this ambitious target.

Key Takeaways:

  • ViiV Healthcare endorses the consensus statement on ending AIDS and HIV as a public health threat in Europe by 2030, calling for increased political, policy, and budgetary priority for HIV, TB, viral hepatitis, and STIs.
  • The statement was developed in collaboration with WHO Europe and UNAIDS, and outlines essential steps for the European Commission and its Member States to meet the ambitious target.
  • Key themes of the consensus statement include strengthening political and community leadership, scaling up testing, enhancing prevention and treatment access, tackling stigma and discrimination, increasing funding and resource allocation, improving data collection, and boosting EU leadership.
  • The statement emphasizes the need for the European Commission and its Member States to take decisive actions to meet the goal of ending AIDS and HIV as a public health threat by 2030.
  • ViiV Healthcare's Senior Vice President and Head of Europe, Jean-Bernard Simeon, fully supports the consensus statement, highlighting the company's commitment to investing in the development of medicines and ensuring equitable access to HIV prevention, treatment, and care.

Statistics:

  • 2030: The target year for Ending AIDS and HIV as a public health threat in Europe, as outlined in the consensus statement.
  • 2024-2029: The new EU Commission mandate period, during which HIV, TB, viral hepatitis, and STIs are to be made a political, policy, and budgetary priority.
  • 2024-2029: The period during which the European Commission and its Member States are expected to allocate necessary resources to the EU Global Health Strategy to fight against HIV and AIDS in third countries.
  • 66-77%: The percentage of patients starting antiretroviral therapy (ART) in the European region, who achieve viral suppression, as reported by UNAIDS.

Sources:

  • ViiV Healthcare (ViiV Healthcare: Press Release: August 26).

Read more